ADMP News and Press, Adamis Pharmaceuticals Corporation From 08/10/22

SAN DIEGO, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company primarily focused on developing and commercializing products in various therapeutic areas, including allergy, opioid overdose, respiratory and inf...

SAN DIEGO, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a biopharmaceutical company developing and commercializing specialty products for allergy, opioid overdose, respiratory and inflammatory disease, today announced that it will host an inve...

3 Things to Look For to Find Penny Stocks to Buy Right Now If you’re looking for penny stocks to buy, there are hundreds of stocks to choose from each day. But with so many stocks to pick from, how can you know which stocks are the best penny stocks to buy ? There are a few t...

Adamis Pharmaceuticals ( NASDAQ: ADMP ) on Friday said the next meeting of a data safety board to review interim results from the company's ongoing phase 2/3 trial of its potential COVID-19 treatment had been set for late Sept. ADMP in the mid-to-late stage trial ...

ISS Recommends Stockholders Support Key Proposals Pertaining to a Reverse Stock Split and New Equity Incentive Plan The Deadline for Stockholders to Vote (or Change Their Vote) is 11:59 p.m. PT on August 11, 2022 SAN DIEGO, July 29, 2022 (GLOBE NEWSWIRE) -- ...

Adamis Pharmaceuticals ( NASDAQ: ADMP ) CEO David Marguglio has penned a letter to shareholders urging them to vote in favor of several proposals at its August annual meeting, including authorizing a potential reverse stock split . In Thursday morning trading, shares a...

SAN DIEGO, July 21, 2022 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a biopharmaceutical company developing and commercializing specialty products for allergy, opioid overdose, respiratory and inflammatory diseases, issued the following letter to stockholders ...

SAN DIEGO, May 26, 2022 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (Nasdaq: ADMP) today announced the appointment of Vickie Reed as a new director and member of the company’s board of directors. Richard Williams, Chairman of the Board, commented: “We are ...

Adamis Pharmaceuticals (NASDAQ:ADMP) on Wednesday said it had appointed co-founder and chief business officer David Marguglio as its new president and CEO. Marguglio replaces Dennis Carlo, who has also stepped down from the board, effective immediately. Carlo led ADMP to three U.S. FDA produc...

David J. Marguglio, Co-Founder and Chief Business Officer, Appointed President and CEO Dennis J. Carlo, Ph.D., Has Retired as Both CEO and Board Director SAN DIEGO, May 18, 2022 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a biopharmaceuti...